Your browser doesn't support javascript.
loading
Cáncer sincrónico y metacrónico detectado con PET/CT en población oncológica / Multiple primary malignant neoplasms detected by PET/CT in cancer patients
Ladrón de Guevara, David; Quera, Rodrigo; Rozas, Sebastián; Schacher, Shmuel; Reyes, José Miguel; Pardo, Claudio; Pefaur, Raúl.
Afiliação
  • Ladrón de Guevara, David; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Quera, Rodrigo; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Rozas, Sebastián; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Schacher, Shmuel; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Reyes, José Miguel; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Pardo, Claudio; Clínica Las Condes. Departamento de Radiología. Santiago. CL
  • Pefaur, Raúl; Clínica Las Condes. Departamento de Radiología. Santiago. CL
Rev. méd. Chile ; 145(11): 1421-1428, nov. 2017. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-902462
Biblioteca responsável: BR1.1
RESUMEN
Background Imaging with F18-fluorodeoxyglucose PET/CT is used to determine sites of abnormal glucose metabolism and can be used to characterize and localize many types of tumors. Aim To assess the prevalence of multiple primary malignant neoplasms (MPMN) detected by PET/CT in cancer patients. Material and Methods F18-fluorodeoxyglucose PET/CT scans performed to 800 patients with a newly diagnosed cancer or with already treated tumors were retrospectively reviewed. In patients whose examination described incidental findings not related to the primary tumor, a research was done about further laboratory, imaging or pathological studies. Results In 188 PET/CT scans (23%) an incidental finding was found. Of these, 66 (35%) were considered as MPMN, 12 as atypical metastases of a known primary tumor, 14 as false positive images (inflammatory or physiologic uptake) and 29 as benign or low grade tumors. In 67 cases (36% of all incidental tumors), the finding was not confirmed. Seven percent of patients with a newly diagnosed tumor had a synchronic MPMN detected by PET/CT. Nine percent of patients with treated tumors developed a metachronous MPMN during their follow up. The most common incidental tumors were thyroid cancer in 15 cases, kidney cancer in 13, lung cancer in 10, colorectal carcinoma in 9, breast cancer in 6, prostate cancer in 4, non-Hodgkin lymphoma in 3 and pancreatic cancer in 2. Conclusions A MPMN is detected by PET/CT in a significant number of cancer patients.

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Idioma: Espanhol Revista: Rev. méd. Chile Assunto da revista: Medicina Ano de publicação: 2017 Tipo de documento: Artigo País de afiliação: Chile Instituição/País de afiliação: Clínica Las Condes/CL

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: LILACS Idioma: Espanhol Revista: Rev. méd. Chile Assunto da revista: Medicina Ano de publicação: 2017 Tipo de documento: Artigo País de afiliação: Chile Instituição/País de afiliação: Clínica Las Condes/CL
...